IMARC Group has recently released a report titled “Giant Cell Arteritis Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)” that presents a comprehensive assessment of the giant cell arteritis market size. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market size, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the giant cell arteritis market.
Giant cell arteritis is a type of systemic vasculitis that hampers the medium- to large-sized arteries, especially the temporal arteries, which run along the sides of the head. The condition causes inflammation in the walls of the arteries, resulting in narrowing or blocking the blood flow. The symptoms of giant cell arteritis include severe headaches, jaw pain while chewing, fever, fatigue, muscle aches, scalp tenderness, vision loss, etc. The diagnosis of this ailment involves a combination of clinical evaluation, blood tests, imaging procedures, and ultrasound or angiography.
Request a Free Sample Report: https://www.imarcgroup.com/giant-cell-arteritis-market/requestsample
The growing cases of autoimmune disorders, in which the body’s immune system attacks healthy tissues and leads to inflammation in the blood vessels, are primarily driving the giant cell arteritis market. Additionally, the rising prevalence of various potential risk factors, such as respiratory infections, advancing age, and inflammatory diseases like polymyalgia, rheumatism, etc., is also catalyzing the market growth. Furthermore, the escalating adoption of aspirin with immunosuppressive drugs for minimizing the formation of blood clots and other complications in patients is creating a positive outlook for the market.
Apart from this, the increasing popularity of biologic therapies, including tocilizumab, abatacept, anakinra, etc., to target specific components of the immune system involved in the inflammatory process is acting as another significant growth-inducing factor. Moreover, the inflating employment of corticosteroid-sparing strategies owing to their various associated benefits, such as minimal side effects, improved disease control, and a reduced risk of relapse, is anticipated to propel the giant cell arteritis market in the coming years.
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the giant cell arteritis market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the giant cell arteritis market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with TOC List of figures: https://www.imarcgroup.com/giant-cell-arteritis-market
Key Questions Answered in this Report :
- How has the giant cell arteritis market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the giant cell arteritis market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the giant cell arteritis market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Browse the Latest Research Report:
Chronic Kidney Disease Market Report 2023-2033
Cryoglobulinemia Market Report 2023-2033
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
